FDA
approval
· 2021-12-15
FDA Approved: TARPEYO — Original Application (Calliditas Therapeutics AB)
Summary
FDA approved Tarpeyo (budesonide) from Calliditas Therapeutics AB through an original application for the treatment of IgA nephropathy. This marks the formal re…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TARPEYO (BUDESONIDE)